在初级保健中优化固定剂量联合疗法在心血管风险因素治疗中的依从性。

IF 0.9 Q4 PRIMARY HEALTH CARE
F.J. Alonso Moreno , J. Espinosa García , F. López Simarro , L. Aliaga Gutiérrez , C. Montero Peña , A. Manzano Vilches , M. Ricote Belinchón , P. Panero Hidalgo , C. Escobar Cervantes
{"title":"在初级保健中优化固定剂量联合疗法在心血管风险因素治疗中的依从性。","authors":"F.J. Alonso Moreno ,&nbsp;J. Espinosa García ,&nbsp;F. López Simarro ,&nbsp;L. Aliaga Gutiérrez ,&nbsp;C. Montero Peña ,&nbsp;A. Manzano Vilches ,&nbsp;M. Ricote Belinchón ,&nbsp;P. Panero Hidalgo ,&nbsp;C. Escobar Cervantes","doi":"10.1016/j.semerg.2024.102337","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Provide consensus recommendations for the optimal management of fixed-dose combination therapies (FCT) in patients with cardiovascular risk factors (CVRF) in primary care (PC).</div></div><div><h3>Material and methods</h3><div>A modified Delphi technique was used. A scientific committee wrote 80 statements addressing controversial issues regarding adherence and the use of FCT in patients with CVRF. A panel of 52 PC specialists, experts in CVRF management and adherence evaluated the questionnaire in two rounds. The work was promoted by the Network of Experts in Adherence in Primary Care (REAAP).</div></div><div><h3>Results</h3><div>Agreement was reached on 66 of the 80 issues (82.5%). The panellists considered that the adherence of patients with CVRF treated in PC was inadequate, which could have clinical implications. The use of FCT might increase adherence compared to separate treatments. FCT usage promotion in PC was considered necessary, especially in polymedicated patients. Measures such as establishing specific protocols or improving the training of professionals in the FTC use are necessary. The FTC use was recommended as a reduction in long-term cardiovascular events in hypertension was observed, together with changes of the concept of high-intensity statins to high-intensity lipid-lowering therapy in dyslipidemia, or considering the use of FCT if the option was available in type 2 diabetes mellitus.</div></div><div><h3>Conclusions</h3><div>The expert consensus recommendations from this work may facilitate the use of FCT in patients with CVRF in PC.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 1","pages":"Article 102337"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care\",\"authors\":\"F.J. Alonso Moreno ,&nbsp;J. Espinosa García ,&nbsp;F. López Simarro ,&nbsp;L. Aliaga Gutiérrez ,&nbsp;C. Montero Peña ,&nbsp;A. Manzano Vilches ,&nbsp;M. Ricote Belinchón ,&nbsp;P. Panero Hidalgo ,&nbsp;C. Escobar Cervantes\",\"doi\":\"10.1016/j.semerg.2024.102337\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Provide consensus recommendations for the optimal management of fixed-dose combination therapies (FCT) in patients with cardiovascular risk factors (CVRF) in primary care (PC).</div></div><div><h3>Material and methods</h3><div>A modified Delphi technique was used. A scientific committee wrote 80 statements addressing controversial issues regarding adherence and the use of FCT in patients with CVRF. A panel of 52 PC specialists, experts in CVRF management and adherence evaluated the questionnaire in two rounds. The work was promoted by the Network of Experts in Adherence in Primary Care (REAAP).</div></div><div><h3>Results</h3><div>Agreement was reached on 66 of the 80 issues (82.5%). The panellists considered that the adherence of patients with CVRF treated in PC was inadequate, which could have clinical implications. The use of FCT might increase adherence compared to separate treatments. FCT usage promotion in PC was considered necessary, especially in polymedicated patients. Measures such as establishing specific protocols or improving the training of professionals in the FTC use are necessary. The FTC use was recommended as a reduction in long-term cardiovascular events in hypertension was observed, together with changes of the concept of high-intensity statins to high-intensity lipid-lowering therapy in dyslipidemia, or considering the use of FCT if the option was available in type 2 diabetes mellitus.</div></div><div><h3>Conclusions</h3><div>The expert consensus recommendations from this work may facilitate the use of FCT in patients with CVRF in PC.</div></div>\",\"PeriodicalId\":53212,\"journal\":{\"name\":\"Medicina de Familia-SEMERGEN\",\"volume\":\"51 1\",\"pages\":\"Article 102337\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina de Familia-SEMERGEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1138359324001473\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PRIMARY HEALTH CARE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina de Familia-SEMERGEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1138359324001473","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0

摘要

摘要为基层医疗机构(PC)对具有心血管风险因素(CVRF)的患者进行固定剂量联合疗法(FCT)的最佳管理提供共识建议:材料与方法:采用改良德尔菲技术。一个科学委员会针对心血管风险因素患者在坚持治疗和使用 FCT 方面的争议问题撰写了 80 份声明。由 52 名 PC 专家、CVRF 管理专家和依从性专家组成的小组对问卷进行了两轮评估。这项工作由初级保健依从性专家网络(REAAP)推动:结果:在 80 个问题中,有 66 个(82.5%)达成了一致意见。小组成员认为,在 PC 中接受治疗的 CVRF 患者的依从性不足,这可能会对临床产生影响。与单独治疗相比,使用 FCT 可提高依从性。他们认为有必要在 PC 中推广 FCT 的使用,尤其是在使用多种药物的患者中。有必要采取措施,如制定具体方案或加强对专业人员使用 FTC 的培训。由于观察到高血压患者的长期心血管事件有所减少,因此建议使用 FTC,同时改变高强度他汀类药物的概念,对血脂异常患者进行高强度降脂治疗,或考虑在 2 型糖尿病患者可以选择的情况下使用 FCT:本研究提出的专家共识建议有助于在 PC 中的 CVRF 患者中使用 FCT。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care

Objective

Provide consensus recommendations for the optimal management of fixed-dose combination therapies (FCT) in patients with cardiovascular risk factors (CVRF) in primary care (PC).

Material and methods

A modified Delphi technique was used. A scientific committee wrote 80 statements addressing controversial issues regarding adherence and the use of FCT in patients with CVRF. A panel of 52 PC specialists, experts in CVRF management and adherence evaluated the questionnaire in two rounds. The work was promoted by the Network of Experts in Adherence in Primary Care (REAAP).

Results

Agreement was reached on 66 of the 80 issues (82.5%). The panellists considered that the adherence of patients with CVRF treated in PC was inadequate, which could have clinical implications. The use of FCT might increase adherence compared to separate treatments. FCT usage promotion in PC was considered necessary, especially in polymedicated patients. Measures such as establishing specific protocols or improving the training of professionals in the FTC use are necessary. The FTC use was recommended as a reduction in long-term cardiovascular events in hypertension was observed, together with changes of the concept of high-intensity statins to high-intensity lipid-lowering therapy in dyslipidemia, or considering the use of FCT if the option was available in type 2 diabetes mellitus.

Conclusions

The expert consensus recommendations from this work may facilitate the use of FCT in patients with CVRF in PC.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicina de Familia-SEMERGEN
Medicina de Familia-SEMERGEN PRIMARY HEALTH CARE-
CiteScore
1.40
自引率
18.20%
发文量
83
审稿时长
39 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信